Literature DB >> 10789719

The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts.

T Danielsen1, E K Rofstad.   

Abstract

Angiogenesis of tumours might develop as a result of environmental conditions, such as hypoxia, and/or as a result of genetic alterations specific for tumour cells. The relative contributions of these mechanisms were investigated by comparing the in vivo expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) to the hypoxic fraction, the angiogenic potential and the vascular density of four human melanoma lines (A-07, D-12, R-18, U-25) grown intradermally in Balb/c nu/nu mice. VEGF expression, bFGF expression and expression of pimonidazole, a marker of hypoxic cells, were investigated by immunohistochemistry. An association between high VEGF and bFGF expression and high angiogenic potential was detected, suggesting an important role for VEGF/bFGF in the angiogenesis of melanomas. High VEGF/bFGF expression was also related to low hypoxic fraction and high vascular density. Thus, the constitutive, genetically determined level of VEGF was probably more important than hypoxia-induced upregulation in the angiogenesis of the melanoma xenografts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789719      PMCID: PMC2363386          DOI: 10.1054/bjoc.2000.1173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Expression of basic fibroblast growth factor in normal human tissues.

Authors:  C Cordon-Cardo; I Vlodavsky; A Haimovitz-Friedman; D Hicklin; Z Fuks
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

2.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors:  K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

3.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

4.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

5.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

Authors:  D Shweiki; M Neeman; A Itin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

6.  Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.

Authors:  A J Pötgens; N H Lubsen; M C van Altena; J G Schoenmakers; D J Ruiter; R M de Waal
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

7.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.

Authors:  F Goto; K Goto; K Weindel; J Folkman
Journal:  Lab Invest       Date:  1993-11       Impact factor: 5.662

8.  Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.

Authors:  A J Guidi; G Abu-Jawdeh; B Berse; R W Jackman; K Tognazzi; H F Dvorak; L F Brown
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

9.  Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.

Authors:  L Hlatky; C Tsionou; P Hahnfeldt; C N Coleman
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

10.  Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  7 in total

Review 1.  Angiogenesis and melanoma.

Authors:  J P Dutcher
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

2.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Hypoxia and VEGF mRNA expression in human tumors.

Authors:  L S Ziemer; C J Koch; A Maity; D P Magarelli; A M Horan; S M Evans
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

5.  Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.

Authors:  Boris Gorelik; Irit Ziv; Revital Shohat; Michael Wick; W David Hankins; David Sidransky; Zvia Agur
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

6.  Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.

Authors:  E K Rofstad; E F Halsør
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

7.  Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma.

Authors:  Steffen Eikenberry; Craig Thalhauser; Yang Kuang
Journal:  PLoS Comput Biol       Date:  2009-04-24       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.